宫颈癌术前使用伊立替康联合顺铂方案化疗的近期疗效观察

短篇论著

陈克明, 易村犍, 易清华, 魏华

全文 ( ) 下载PDF ( ) 导出引用

	1　Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55: 74-108.
	2　Zhao EF, Bao L, Li C, et al. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50 years [J]. J Southern Med Univ, 2005, 25(6): 605-609.
	3　Frei E. Clinical cancer research: An embattled specics [J]. Cancer, 1982, 50(100): 1979-1992.
	4　Guan MF，Huang H，Liu JH. Clinical effects of neoadjuvant chemotherapy on early-stage bulky cervical carcinoma [J]. Chin J Clin Obstet Gynecol, 2008，9(3)：170-173. [关明飞，黄鹤，刘继红. 新辅助化疗对早期巨块型宫颈癌作用的临床分析[J]．中国妇产科临床杂志，2008，9(3)：170-173.]
	5　Li XC, He T, Li ZW. Neoadjuvant chemotherapy for cervical cancer [J]. J Int Oncol, 2007, 34(8)：621-623. [李希聪，何涛，李振伟．宫颈癌的新辅助化疗[J]．国际肿瘤学杂志，2007, 34(8)：621-623.]
	6　Hwang YY, Moon H, Cho SH, et al.Ten-year survival of patients with locally advanced stage ⅠB-ⅡB cervical cancer after neoadjuvant chemotherapy and radical hysterectomy [J]. Gynecol Oncol, 2001, 82(1): 88-93.
	7　Sugiyama T, Nishida T, Kumagai S, et al. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer [J]. Cancer, 1999, 81: 95-98.

No related articles found!

阅读次数

全文

摘要